Reporte zur Charge UJ81AAA

Symptomtext

YF-Vax was administered with a different diluent with no reported adverse event; Initial information was received on 25-May-2023 regarding an unsolicited valid non-serious case received from a nurse. This case involves an unknown age and gender patient who was administered with a different diluent with no reported adverse event after receiving yellow fever vaccine [Yf-Vax]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received an unknown dose of suspect yellow fever vaccine Solution for injection (lot: UJ81AAA, expiry date: 18-Apr-2024, strength: unknown) via unknown route in unknown administration site for Immunization. On an unknown date the patient was administered with a different diluent with no reported adverse event (product preparation error) (unknown latency) following the administration of yellow fever vaccine. Caller asked if the 0.7 ml Sterile water that they used as diluent was compatible to YF-VAX. Action taken: not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.